Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-03

MLYS vs OMER: stock comparison and AI forecast

Mineralys Therapeutics, Inc. (MLYS) and Omeros Corp (OMER) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

MLYS Mineralys Therapeutics, Inc.

Market Cap
$1.37B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

OMER Omeros Corp

Price
$18.44 +26.3% · 6M
Market Cap
$1.33B
P/E Ratio
34.8x
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

MLYS · OMER

Key facts

  • MLYS and OMER have similar market capitalizations ($1.37B and $1.33B).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricMLYSOMER
Market Cap$1.37B$1.33B
P/E Ratio–34.79x
P/B Ratio2.50x–
EPS$-4.48$0.53
Book Value/Share$6.23–
FCF/Share–$-0.95

Profitability & Margins

MetricMLYSOMER
ROE-63.5%–
ROA-52.3%–
ROIC-57.2%-38.0%
Tax Rate–1.6%

Financial Health

MetricMLYSOMER
Current Ratio34.46x1.95x
Quick Ratio–1.94x
D/E Ratio0.21x–
Financial Leverage1.21x–
Interest Coverage–0.0x
Working Capital$646M$90M

Cash Flow

MetricMLYSOMER
Operating Cash Flow-$139M-$69M
Free Cash Flow–-$69M
Capital Spending–-$60K

Income Statement

MetricMLYSOMER
Operating Income-$371M-$73M
Net Income-$350M–
R&D Expense$302M$63M
SG&A Expense–$47M

Dividend & Shareholder Information

MetricMLYSOMER
Shares Outstanding88M72M
FAQ

MLYS vs OMER: stock comparison and AI forecast

Which is bigger, MLYS or OMER?

MLYS and OMER have similar market capitalizations ($1.37B and $1.33B).

Which one does Intratio's AI model rank higher, MLYS or OMER?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.